Yttrium-90 radioembolization for hepatocellular carcinoma

Ryan M. Hickey, Robert J. Lewandowski, Riad Salem*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


90Y radioembolization refers to the selective, transcatheter, and intra-arterial injection of micrometer-sized particles loaded with the radioisotope yttrium-90 for the treatment of primary and metastatic hepatic malignancies. In the treatment of intermediate- and advanced-stage hepatocellular carcinoma, 90Y radioembolization provides favorable outcomes with minimal side effects, offering an alternative treatment option to other transarterial therapies, such as bland embolization and chemoembolization. This review provides an overview of the use of 90Y radioembolization in the treatment of hepatocellular carcinoma, including patient selection criteria, dosimetry, and clinical outcomes.

Original languageEnglish (US)
Pages (from-to)105-108
Number of pages4
JournalSeminars in Nuclear Medicine
Issue number2
StatePublished - Mar 1 2016

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Yttrium-90 radioembolization for hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this